Literature DB >> 22610603

Development of SI-traceable C-peptide certified reference material NMIJ CRM 6901-a using isotope-dilution mass spectrometry-based amino acid analyses.

Tomoya Kinumi1, Mari Goto, Sakae Eyama, Megumi Kato, Takeshi Kasama, Akiko Takatsu.   

Abstract

A certified reference material (CRM) is a higher-order calibration material used to enable a traceable analysis. This paper describes the development of a C-peptide CRM (NMIJ CRM 6901-a) by the National Metrology Institute of Japan using two independent methods for amino acid analysis based on isotope-dilution mass spectrometry. C-peptide is a 31-mer peptide that is utilized for the evaluation of β-cell function in the pancreas in clinical testing. This CRM is a lyophilized synthetic peptide having the human C-peptide sequence, and contains deamidated and pyroglutamylated forms of C-peptide. By adding water (1.00 ± 0.01) g into the vial containing the CRM, the C-peptide solution in 10 mM phosphate buffer saline (pH 6.6) is reconstituted. We assigned two certified values that represent the concentrations of total C-peptide (mixture of C-peptide, deamidated C-peptide, and pyroglutamylated C-peptide) and C-peptide. The certified concentration of total C-peptide was determined by two amino acid analyses using pre-column derivatization liquid chromatography-mass spectrometry and hydrophilic chromatography-mass spectrometry following acid hydrolysis. The certified concentration of C-peptide was determined by multiplying the concentration of total C-peptide by the ratio of the relative area of C-peptide to that of the total C-peptide measured by liquid chromatography. The certified value of C-peptide (80.7 ± 5.0) mg/L represents the concentration of the specific entity of C-peptide; on the other hand, the certified value of total C-peptide, (81.7 ± 5.1) mg/L can be used for analyses that does not differentiate deamidated and pyroglutamylated C-peptide from C-peptide itself, such as amino acid analyses and immunochemical assays.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610603     DOI: 10.1007/s00216-012-6097-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  7 in total

Review 1.  Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned.

Authors:  Randie R Little; Robert I Wielgosz; Ralf Josephs; Tomoya Kinumi; Akiko Takatsu; Hongmei Li; Daniel Stein; Chris Burns
Journal:  Clin Chem       Date:  2017-06-23       Impact factor: 8.327

2.  Characterization and Value Assignment of a Monoclonal Antibody Reference Material, NMIJ RM 6208a, AIST-MAB.

Authors:  Tomoya Kinumi; Kazumi Saikusa; Megumi Kato; Reiko Kojima; Chieko Igarashi; Naohiro Noda; Shinya Honda
Journal:  Front Mol Biosci       Date:  2022-06-06

3.  Survey of peptide quantification methods and comparison of their reproducibility: A case study using oxytocin.

Authors:  Chensheng Li; Sitaram Bhavaraju; Marie-Pier Thibeault; Jeremy Melanson; Andreas Blomgren; Torgny Rundlöf; Eric Kilpatrick; Carolyn J Swann; Timothy Rudd; Yves Aubin; Kevin Grant; Margaret Butt; WaiKei Shum; Tursun Kerim; William Sherwin; Yukari Nakagawa; Sergi Pavón; Silvia Arrastia; Tim Weel; Arunima Pola; Dinesh Chalasani; Steven Walfish; Fouad Atouf
Journal:  J Pharm Biomed Anal       Date:  2018-12-19       Impact factor: 3.935

4.  Implementing a Reference Measurement System for C-Peptide: An Addendum.

Authors:  Randie R Little; Tomoya Kinumi; Shawn Connolly; Kuanysh Kabytaev
Journal:  Clin Chem       Date:  2017-10-04       Impact factor: 8.327

5.  Characterization of a SARS-CoV-2 spike protein reference material.

Authors:  Bradley B Stocks; Marie-Pier Thibeault; Joseph D Schrag; Jeremy E Melanson
Journal:  Anal Bioanal Chem       Date:  2022-03-09       Impact factor: 4.478

6.  Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China.

Authors:  Weiyan Zhou; Yuhang Deng; Haijian Zhao; Chuanbao Zhang
Journal:  Ann Lab Med       Date:  2022-07-01       Impact factor: 4.941

Review 7.  C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.

Authors:  Ernesto Maddaloni; Geremia B Bolli; Brian M Frier; Randie R Little; Richard D Leslie; Paolo Pozzilli; Raffaela Buzzetti
Journal:  Diabetes Obes Metab       Date:  2022-06-28       Impact factor: 6.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.